Jounce Therapeutics, Inc.

JNCEDelisted May 4, 2023

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001640455

SEC filings (opens in a new tab)

Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.

Superinvestors holding JNCE, Q1 2023

See all superinvestors

No superinvestor reported holding JNCE in Q1 2023.